Literature DB >> 21953432

[Commentary on the planned restructuring of mammography screening in Austria].

Christian Vutuc1, Gerald Haidinger.   

Abstract

With regards to the planned reorganisation of screening mammography in Austria - from an opportunistic to an organised system - the problems related with such a change are depicted from an epidemiological point of view. We were able to demonstrate earlier that opportunistic screening mammography matches the results of controlled screening mammography in Finland and Sweden. Switching to a controlled system in Austria would - besides the need for a change in legislation - lead to enormous expenditures in terms of resources needed and moreover, it could be not evaluated for years.

Mesh:

Year:  2011        PMID: 21953432     DOI: 10.1007/s10354-011-0020-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

1.  Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.

Authors:  C Vutuc; G Haidinger; T Waldhoer; F Ahmad; G Breitenecker
Journal:  Wien Klin Wochenschr       Date:  1999-05-07       Impact factor: 1.704

2.  Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden.

Authors:  Christian Vutuc; Thomas Waldhoer; Gerald Haidinger
Journal:  Eur J Cancer Prev       Date:  2006-08       Impact factor: 2.497

3.  Survival of women with breast cancer in Austria by age, stage and period of diagnosis.

Authors:  Christian Vutuc; Thomas Waldhoer; Jeannette Klimont; Gerald Haidinger; Raimund Jakesz; Ernst Kubista; Christoph Zielinski
Journal:  Wien Klin Wochenschr       Date:  2002-06-28       Impact factor: 1.704

4.  Self-reported Pap smear screening in Austria.

Authors:  Gerald Haidinger; Thomas Waldhoer; Christian Vutuc
Journal:  Wien Med Wochenschr       Date:  2008

5.  Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria.

Authors:  C Vutuc; G Haidinger; T Waldhoer
Journal:  Wien Klin Wochenschr       Date:  1998-07-31       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.